The core of synthetic biotechnology lies in the design and remake of enzymes, metabolic pathways, and chassis cells, all of which Abiochem has established solid foundations. To date, we have developed a large enzyme library that covers twenty-one kinds of frequently used industrial enzymes ( 50,000+), including transaminase. In addition, we have developed a highly effective enzyme design platform, which can create improved and brand-new enzyme mutations using machine learning to predict and screen enzymes based on the need for catalytic reaction, thereby achieving rapid artificial evolution of enzymes through high-throughput screening and testing. Moreover, our gene assembling and editing platform enables us to design a variety of gene elements and reassemble the metabolic pathway of biological chassis. Furthermore, we have built the genetic elements library (100,000+) and finalized chassis cells for more than 90 high performance strains, including Escherichia coli, Saccharomyces cerevisiae, Corynebacterium glutamicum, etc.